Aortic stent grafts market seen reaching $5.3 billion by 2030

The Business Research Company says the aortic stent grafts market will grow from $3.59 billion in 2025 to $3.9 billion in 2026, then reach $5.3 billion by 2030. The report points to rising aneurysm cases, broader use of minimally invasive repair and expanding screening as the main growth drivers.

Why it matters: - Aortic stent grafts are used to treat weakened areas of the aorta and help reduce the risk of life-threatening complications. - The market outlook points to rising demand for minimally invasive vascular treatment as cardiovascular disease rates increase and health systems look to shorten hospital stays. - Growth in this category also reflects broader adoption of EVAR and TEVAR procedures for abdominal and thoracic aortic aneurysms.

What happened: - The Business Research Company released a report on the global aortic stent grafts market on July 25, 2026. - The report estimates the market will grow from $3.59 billion in 2025 to $3.9 billion in 2026, an 8.8% CAGR. - The report forecasts the market will reach $5.3 billion by 2030, with a 7.9% CAGR over the forecast period. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region through the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - The market growth in 2025-2026 is driven by more abdominal and thoracic aortic aneurysm cases, early adoption of EVAR and TEVAR, improved vascular surgery infrastructure and wider access to endovascular device technologies. - An aging population with higher cardiovascular risk is also supporting demand. - The 2030 outlook is tied to higher procedure volumes in ambulatory and outpatient settings, stronger demand for advanced and hybrid stent graft systems, and more screening for aortic aneurysm detection. - The report also cites ongoing investment in minimally invasive vascular therapies. - Future demand is expected to favor modular and customizable stent graft designs and next-generation graft materials with more flexibility and durability. - Use of stent grafts in complex abdominal and thoracic aneurysm cases is expanding. - Earlier intervention to prevent aneurysm rupture is becoming more common. - The report defines aortic stent grafts as fabric grafts reinforced by a metal stent and inserted through minimally invasive procedures. - The devices are used to support weakened sections of the aorta and treat aneurysms and other conditions that affect the vessel wall. - Rising cardiovascular disease is a core demand driver, with unhealthy diets, sedentary lifestyles, smoking and obesity contributing to higher case counts. - The British Heart Foundation said in January 2024 that coronary heart disease remains a leading cause of death in the UK, causing about 68,000 deaths a year. - The British Heart Foundation also said CHD accounts for one in eight male deaths and one in 14 female deaths in the UK.

Between the lines: - The report’s strongest signal is not just market growth, but a shift in where and how these procedures are done. - More outpatient care, more screening and earlier intervention suggest the category is moving upstream, before patients reach emergency or advanced disease stages. - The emphasis on hybrid systems, modular designs and durable materials points to a market competing on procedure fit and clinical flexibility, not just volume.

What's next: - The market is expected to keep expanding as aneurysm detection programs widen and minimally invasive repair becomes the preferred approach in more cases. - Regional growth momentum may increasingly shift toward Asia-Pacific as adoption broadens across healthcare systems. - The report package includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and trend analysis.